Laboratory Testing for Activated Protein C Resistance (APCR): An Update

Emmanuel J Favaloro, Soma Mohammed, Ronny Vong, Leonardo Pasalic

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Activated protein C resistance (APCR) reflects a hemostatic state defined by a reduced ability of activated protein C (APC) to affect an anticoagulant response. This state of hemostatic imbalance is characterized by a heightened risk of venous thromboembolism. Protein C is an endogenous anticoagulant that is produced by the hepatocytes and undergoes proteolysis-mediated activation to APC. APC in turn degrades activated Factors V and VIII. APCR describes a state of resistance by activated Factors V and VIII to APC-mediated cleavage of these factors, thereby promoting amplified thrombin production and a potentially procoagulant state. This resistance of APC may be inherited or acquired. Mutations in Factor V are responsible for the most frequent form hereditary APCR. The predominant mutation, a G1691A missense mutation at Arginine 506, the so-called Factor V Leiden [FVL], causes a deletion of an APC-targeted cleavage site in Factor Va, thereby rendering it resistant to inactivation by APC. There are a variety of laboratory assays for APCR, but this chapter focuses on a procedure using a commercially available clotting assay that utilizes a snake venom and ACL TOP analyzers.

Original languageEnglish
Pages (from-to)203-210
Number of pages8
JournalMethods in Molecular Biology
Publication statusPublished - 2023


Dive into the research topics of 'Laboratory Testing for Activated Protein C Resistance (APCR): An Update'. Together they form a unique fingerprint.

Cite this